Clinical Trial Update: Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anticoagulation for pulmonary hypertension in patients with sickle cell disease was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sickle Cell Disease

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pulmonary Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2014-02-21